Abstract
Hepatitis E virus (HEV) as a recognized zoonotic pathogen has posed global burden on public health, which is exacerbated by lack of efficient vaccine. In this study, we constructed a recombinant (inaQ-ORF2 gene fusion) Lactococcus lactis (L. lactis) strain NZ3900 that expresses and displays the hepatitis E virus antigen ORF2 utilizing an ice uncleation protein-based anchor system. After oral vaccination of BALB/c mice, significantly higher levels of ORF2-specific mucosal IgA and serum IgG were detected and cellular immunity was also induced. These findings further support that L. lactis-based HEV antigen vaccines could be used for human and animal protection against infection.
Keywords:
Hepatitis E virus; Ice nucleation protein; Lactococcus lactis; Oral immunization.
Copyright © 2014 Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Animals
-
Bacterial Outer Membrane Proteins / genetics
-
Female
-
Hepatitis E / immunology
-
Hepatitis E / prevention & control*
-
Hepatitis E virus / immunology*
-
Humans
-
Immunity, Cellular
-
Immunity, Mucosal
-
Immunization
-
Immunoglobulin A / blood
-
Immunoglobulin G / blood
-
Lactococcus lactis / genetics
-
Mice
-
Mice, Inbred BALB C
-
Recombinant Fusion Proteins / genetics
-
Viral Hepatitis Vaccines / administration & dosage
-
Viral Hepatitis Vaccines / immunology*
-
Viral Proteins / genetics
-
Viral Proteins / immunology*
-
Zoonoses / immunology
-
Zoonoses / prevention & control*
Substances
-
Bacterial Outer Membrane Proteins
-
Immunoglobulin A
-
Immunoglobulin G
-
ORF2 protein, Hepatitis E virus
-
Recombinant Fusion Proteins
-
Viral Hepatitis Vaccines
-
Viral Proteins
-
ice nucleation protein